SUMMARY The case is reported of a patient with systemic AA amyloidosis associated with non-specific mesenteric lymphadenitis and chronic sideropenia. Renal, small bowel, and rectal biopsies showed amyloid deposits containing AA protein, as defined by potassium permanganate sensitivity and by reactivity with AA antiserum. Reversal of the nephrotic syndrome occurred during steroid-azathioprine therapy.
The underlying disease in reactive (secondary) amyloidosis is usually a rheumatic, chronic infectious, or '.t *";,I'i-, (jejunal biopsy) or with PAS, Masson's trichrome and periodic acid-silver methenamine (kidney biopsy). To show the amyloid deposits a series of consecutive sections were cut and stained as follows:
(1) with alkaline Congo red;3 (2) Amyloid was also present in arteriolar walls but not in larger vessels. The tubules were slightly atrophic and the interstitium focally fibrotic. The jejunal biopsy specimen showed partial villous atrophy and a moderate amount of amyloid located patchily in the muscularis mucosae and lamina propria (Fig. 2) . In the follow-up biopsy specimen obtained after eight months of gluten-free diet considerable improvement in the villous architecture was seen; the amount of amyloid remained similar. In the rectal biopsy specimen moderate amounts of amyloid occurred in the walls of the submucosal blood vessels, in the muscularis mucosae, and segmentally beneath the surface epithelium. In the renal and gut biopsy specimens the amyloid lost its ability to be stained with Congo red after treatment with potassium permanganate and reacted specifically with anti-AA antiserum (Fig. 3) .
Clinical reversal of the nephrotic syndrome occurred during steroid-azathioprine therapy: proteinuria decreased, serum proteins and cholesterol returned to normal, and oedema was resolved. These """' %"
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Discussion
The tissue distribution, histochemistry, and immunohistochemistry of the amyloid deposits in the present case justify the classification of the amyloid disease as AA amyloidosis. This type of amyloidosis occurs as a complication of inflammatory, infectious, and neoplastic disorders. Repeated examinations for such diseases were negative. Explorative laparotomy revealed multiple mesenteric nodes and enlarged liver but no other abnormalities. The lymph node morphology did not contribute to the diagnosis. In these respects the clinical picture of our patient resembles that described by Pras et al.2
for a case of 'primary' or 'idiopathic' AA amyloidosis. Their patient had no definable underlying disease but like our patient had a markedly raised erythrocyte sedimentation rate, lymphadenopathy, and mild hepatomegaly and an elevated alkaline phosphatase level. Although clinically different from our patient's disease, it is of interest that AA protein was also reported in a Japanese patient with primary type amyloidosis.7
The resemblance of the clinical picture of our case with that of giant lymph node hyperplasia and amyloidosis8 9 is intriguing. However, lymph node morphology in our case lacked the characteristics of giant lymph node hyperplasia.
At the time of the development of the nephrotic syndrome dermatitis herpetiformis appeared. With respect to the formation of amyloid we believe that the dermatitis was unimportant, since it occurred late in the disease history; moreover in a preliminary study of 11 patients with dermatitis herpetiformis we found no amyloid in the jejunal biopsy specimens, and the concentration of SAA was not raised (unpublished). The amount of amyloid in the jejunal biopsy specimens was similar before and after gluten withdrawal, suggesting that the changes in villous architecture were not secondary to amyloid. The villous changes obviously relate to the dermatitis herpetiformis.t) Since no defect in iron absorption could be shown, the chronic hypoferraemia of our patient was probably not related to the villous changes.
The nephrotic syndrome responded to azathioprine-steroid treatment. Since renal biopsy before therapy showed predominantly glomerular amyloid, and no other changes, the cause of the nephrotic syndrome was interpreted as being due to amyloid. Thus the present results suggest that immunosuppressive therapy may be beneficial in the treatment of renal manifestations of AA amyloidosis. However, the results should be interpreted with some caution, since spontaneous remission of nephrotic syndrome in renal amyloidosis has been reported. 1 1 In conclusion the present case could be classified as 'idiopathic' AA amyloidosis, but the justification for the use of such terminology seems questionable, since in spite of our failure to define an underlying chronic inflammatory disease in our patient several laboratory parameters could be interpreted as evidence for the existence of chronic inflammation.
